Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: Phase i study

G. S. Nowakowski, B. Laplant, T. M. Habermann, C. E. Rivera, W. R. MacOn, D. J. Inwards, I. N. Micallef, P. B. Johnston, L. F. Porrata, S. M. Ansell, R. R. Klebig, C. B. Reeder, T. E. Witzig

Research output: Contribution to journal › Article › peer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: Phase i study'. Together they form a unique fingerprint.

Medicine & Life Sciences